Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide Therapy vs Other Donor Transplantations in Adults With Hematologic Cancers-Reference-Cited by-同舟云学术

Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide Therapy vs Other Donor Transplantations in Adults With Hematologic Cancers

Published:2019-12-01 Issue:12 Volume:5 Page:1739
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Gagelmann Nico¹,Bacigalupo Andrea²,Rambaldi Alessandro³,Hoelzer Dieter⁴,Halter Jörg⁵,Sanz Jaime⁶,Bonifazi Francesca⁷,Meijer Ellen⁸,Itälä-Remes Maija⁹,Marková Markéta¹⁰,Solano Carlos¹¹,Kröger Nicolaus¹

Affiliation:

1. Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

2. Fondazione Policlinico Universitario A. Gemelli Institute of Scientific Research and Treatment, Universita' Cattolica del Sacro Cuore, Rome, Italy

3. Hematology and Bone Marrow Transplantation Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy

4. Goethe University Hospital, Department of Medicine II, Hematology/Oncology, Frankfurt am Main, Germany

5. Division of Hematology, Basel University Hospital, Basel, Switzerland

6. Department of Hematology, Hospital Universitari i Politècnic La Fe, Valencia, Spain

7. Department of Hematology, L and A Seràgnoli, University of Bologna, S Orsola-Malpighi Hospital, Bologna, Italy

8. Amsterdam University Medical Center, Vrije Universiteit, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands

9. Turku University Hospital, Turku, Finland

10. Institute for Hematology and Blood Transfusion, Hospital Na Bulovce, Prague, Czech Republic

11. Hospital Clinico Universitario-INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2752787/jamaoncology_gagelmann_2019_oi_190071.pdf

Reference77 articles.

1. Use of haploidentical stem cell transplantation continues to increase.;Passweg;Bone Marrow Transplant,2017

2. Costs of allogeneic hematopoietic cell transplantation with high-dose regimens.;Saito;Biol Blood Marrow Transplant,2008

3. Marrow transplantation from related donors other than HLA-identical siblings.;Beatty;N Engl J Med,1985

4. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.;Szydlo;J Clin Oncol,1997

5. One million haemopoietic stem-cell transplants.;Gratwohl;Lancet Haematol,2015

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Human Leukocyte Antigen-Matched Related Donor and Haploidentical Allogeneic Hematopoietic Cell Transplantation Recipients by Immune Profiles of Recipients and Donors;Transplantation and Cellular Therapy;2024-08

2. Total Body Irradiation and Fludarabine with Post-Transplantation Cyclophosphamide for Mismatched Related or Unrelated Donor Hematopoietic Cell Transplantation;Transplantation and Cellular Therapy;2024-08

3. Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors + Mycophenolate Mofetil versus Sirolimus + Mycophenolate Mofetil;Transplantation and Cellular Therapy;2024-08

4. Effect of peptide‐binding motif on survival of HLA‐haploidentical transplantation with post‐transplant cyclophosphamide;British Journal of Haematology;2024-07-07

5. Haploidentical HSCT in the Treatment of Pediatric Hematological Disorders;International Journal of Molecular Sciences;2024-06-09